Western Blotting Market Size, Growth and Industry Trends by 2027

The global western blotting market accounted to US$ 638.82 Mn in 2018 and is expected to grow at a CAGR of 5.2% during the forecast period 2019 - 2027, to account to US$ 992.55 Mn by 2027.

The market for western blotting is expected to grow significantly due to driving factors such as application in the field of proteomic research, rising prevalence of Lyme and HIV, and increasing investment in R&D by pharmaceutical and biotechnology companies. However, the factor such as alternative technologies for protein detection is likely to act as major restraining factor for the growth of the market.

Download a Comprehensive Report Snapshot @ https://www.theinsightpartners.com/sample/TIPHE100001121/?opr-ss

The major players operating in the western blotting market include, Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland Immunochemicals Inc., and Abcam plc among the others.

The companies are involved in various growth strategies that are enabling the growth of the market as well as for the company. For instance, in June, 2019, Thermo Fisher Scientific Inc. launched iBright 1500 Imaging System Series that includes two models, the Invitrogen iBright FL1500 imaging system and the Invitrogen iBright CL1500 imaging system for life science researchers.

Consumables segment is expected to grow the market for western blotting over the forecast period by product segment.

Global western blotting market was segmented by product, application and end user. The product segment was segmented into instruments and consumables. The instrument segment was further divided into imagers, gel electrophoresis instruments and blotting systems. Like consumables were classified as kits, reagents and others. Based on the application the market was segmented as biomedical & biochemical research, agriculture, and others. Similarly based on the end user the market is segmented as biotechnological & pharmaceutical companies, diagnostic laboratories, academic & research institutes and others.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPHE100001121/?opr-ss

Strategic Insights

Organic and inorganic growth strategies were observed among which organic strategy was the most adopted strategy in global western blotting industry. For instance, in June, 2019. Thermo Fisher Scientific Inc. launched iBright 1500 Imaging System Series that includes two models, the Invitrogen iBright FL1500 imaging system and the Invitrogen iBright CL1500 imaging system for life science researchers. Thus, various product launch in the market are likely to influence the market growth during forecast period.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.